Adverse drug reactions to the sulfonamide antibiotics are uncommon. When they do occur, they usually manifest as a rash or urticaria. Our review of the recent literature found that while sialadenitis is listed as a possible side eff ect of sulfonamide use, no actual case has ever been reported until now. We describe a case of acute bilateral parotitis that arose as a side eff ect of sulfonamide antibiotic treatment. We also examine the relevance of such pathology to the proposed mechanisms of sialadenitis, and we briefl y discuss sulfonamide-induced pancreatitis. Lastly, we review the controversy over the possibility that some adverse drug reactions may be caused by crossreactivity among diff erent classes of sulfonamides. ACUTE PAROTITIS INDUCED BY TRIMETHOPRIM/SULFAMETHOXAZOLE Volume 90, Number 2 www.entjournal.com ■ E23
Introduction
Adverse drug reactions to sulfonamide antibiotics can involve multiple organ systems. Among the most commonly reported side eff ects of these drugs are hypersensitivity reactions involving the skin and mucous membranes. More worrisome adverse eff ects, such as suppression of the hematopoietic system, are rare. Patients who take the fi xed-combination agent trimethoprim/sulfamethoxazole (TMP/SMX) have a higher risk of cutaneous reactions, as well as gastrointestinal and oral manifestations. 1 Th e two components of TMP/SMX synergistically inhibit the production of microbial folate and nucleic acid. TMP/SMX is widely used for the treatment of uncomplicated urinary tract infections, gastrointestinal infections, skin infections, and acute exacerbations of chronic bronchitis.
Drug-induced parotitis is uncommon; when it has occurred, most cases have been associated with anticholinergic medications. 2 We report a case of acute bilateral parotitis that most likely occurred as a result of TMP/SMX therapy. While Tack and Rogers 3 have implicated sulfonamides as a possible cause of sialadenitis, no such case has ever been reported in the literature until now.
Case report
A 44-year-old white man initially presented to an outpatient clinic with a complaint of a maculopapular, pustular rash on his left forearm. His history was signifi cant only for a new tattoo on the same forearm, which he had received a few weeks prior to the onset of the rash. He had no preexisting skin lesions. Wound specimens obtained for culture and sensitivity demonstrated growth of methicillin-resistant Staphylococcus aureus that was susceptible to fl uoroquinolones, vancomycin, and TMP/SMX. Th e patient was initially placed on moxifl oxacin at 400 mg/day for 10 days. However, he discontinued the antibiotic aft er the third dose because of gastrointestinal distress, and he was subsequently placed on TMP/SMX at 160/800 mg twice daily for 15 days.
Aft er the patient had completed 10 days of treatment, he was reevaluated in the clinic. Th e rash had resolved, but the patient reported that he had developed a sudden onset of bilateral parotid swelling with tenderness and erythema a few days earlier. He had discontinued the TMP/SMX at the fi rst sign of the facial swelling. Viral and other infectious etiologies for the swelling were excluded from the list of diff erential diagnoses through analysis of antibody titers. Hepatitis and mononucleosis were also ruled out. Th e only signifi cant laboratory values were an elevated leukocyte count of 13,700/μl accompanied by an increase in neutrophils to 9,500/ μl. Contrast-enhanced computed tomography of the neck and soft tissues showed that the parotid glands were mildly heterogeneous bilaterally with mild reactive cervical adenopathy.
is believed to play a crucial role in extreme cutaneous reactions to these medications. 9 Most adverse reactions to sulfonamide antibiotics appear aft er several doses have been taken, indicating that an immune response is involved. Once the arylamine groups are metabolized, they achieve reactivity and can elicit an immune response by acting as haptens. 10 Studies have documented the presence of T lymphocytes in the skin of patients who experience sulfonamide-induced cutaneous reactions. 11 Such testing was not readily available during the evaluation of our patient.
It should be mentioned that the only other medication that our patient had been taking was hydrochlorothiazide. He had been taking this diuretic as directed for the previous 8 years without experiencing any adverse eff ects. Th e thiazides are among the sulfonamide medications that do not contain the reactive arylamine group. Johnson et al conducted an extensive review of the literature and analyzed numerous case reports and studies supporting the idea of cross-reactivity between the sulfonylarylamines and the nonsulfonylarylamines. 12 With respect to thiazide diuretics, they found that the data did not support a conclusion that adverse reactions were the result of cross-reactivity rather than the actions of an active metabolite of the off ending agent.
Th ese authors agreed with the notion that patients who have tolerated hydrochlorothiazide use in the past are not necessarily suspect for cross-reactivity in the event of an initial allergic reaction to a diff erent class of sulfonamides. 12 Furthermore, reports in the current literature indicate that the concurrent use of arylaminecontaining sulfonamides and nonsulfonylarylamines is not contraindicated in patients who have no history of hypersensitivity reactions. 12, 13 Th erefore, we believe that the onset of acute parotitis in our patient was solely related to the use of TMP/SMX and not a result of any cross-reactivity with hydrochlorothiazide. Th erefore, the future use of sulfonamide antibiotics is relatively contraindicated in our patient. If he were ever to require a sulfonamide, a suitable alternative should be sought; if one is not available, then the use of the sulfonamide should be closely monitored.
In conclusion, we have presented a case of bilateral parotitis believed to be the result of TMP/SMX treatment. To the best of our knowledge, this is the fi rst such case reported in literature. Th ere have been reported cases of TMP/SMX-induced pancreatitis that were believed to be the result of an immune response. Hence, it is likely that the parotitis induced by this sulfonamide Since infectious causes had been ruled out, the patient was treated with supportive therapy. It included one 40-mg/ml subcutaneous injection of methylprednisolone, increased fl uid intake, and discontinuation of the TMP/SMX. Th e patient's symptoms soon began to resolve, and he continued to improve over the next 3 weeks during regular offi ce follow-up.
Discussion
Th e clinical presentation of acute sialadenitis typically consists of tenderness and swelling of the aff ected gland with a variable degree of overlying erythema. A multitude of causes has been attributed to salivary gland swelling, including diabetes mellitus, sialolithiasis, and neoplasms. Acute parotitis is most commonly associated with bacterial and viral infections of the parotid gland. 4 Perhaps the least documented form of parotitis is that which occurs as a side eff ect of medication. Several classes of medication have been suggested as potential etiologic agents. In our review of the literature, we found that the most frequently mentioned drugs were anticholinergics, antihistamines, and antipsychotics. 2, 5 Several cases of phenylbutazone-induced parotitis have also been reported. 2, 3 Th e mechanism by which these adverse reactions occur is believed to be related to hyposalivation and xerostomia, which predispose patients to salivary gland infections. Antipsychotic medications can act directly on the salivary glands by adversely affecting innervation and salivary control. 3, 5, 6 Taguchi et al reported a reaction to methimazole that resulted in acute pancreatitis as well as parotitis. 7 Th e underlying cause in that case was believed to be related to a hypersensitivity reaction. Based on histologic similarities, the authors proposed a possible correlation between the mechanism of injury to the pancreas and the mechanism of injury to the parotid gland. A few cases of TMP/SMX-induced pancreatitis have been reported, but they did not include associated sialadenitis. 8 In all of these reports, the mechanism was not defi nitively established, but it was presumed to be of an allergic nature. Since sulfonamides have also been linked to allergic pancreatitis, it is conceivable that the TMP/SMX-induced parotitis in our patient was the byproduct of an immune response similar to the one reported by Taguchi et al. 7 Th e chemical composition of sulfonamide antibiotics diff ers from that of nonantibiotic sulfonamide compounds in that the molecular structure of the antibiotics contains a primary arylamine group, which antibiotic in our patient was also the consequence of an elicited immune response. Our patient's condition began to resolve with cessation of the TMP/SMX. Given the fact that we suspected that our patient's sialadenitis was caused by a hypersensitivity reaction, the TMP/ SMX was not restarted.
